Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Sales | 4,226,100 | 4,245,301 | 3,864,100 | 3,866,900 | 3,714,700 |
| Cost of Goods | 922,500 | 1,019,000 | 860,400 | 860,600 | 806,500 |
| Gross Profit | 3,303,600 | 3,226,300 | 3,003,700 | 3,006,300 | 2,908,200 |
| Operating Expenses | 2,500,000 | 2,168,800 | 1,954,300 | 2,013,300 | 1,884,200 |
| Operating Income | 804,100 | 1,057,500 | 1,049,800 | 993,600 | 1,024,500 |
| Other Income | -84,700 | -842,500 | 56,000 | 46,900 | 32,200 |
| Pre-tax Income | 719,400 | 215,000 | 1,105,800 | 1,040,500 | 1,056,700 |
| Income Tax | 210,700 | 82,700 | 232,200 | 218,500 | 221,900 |
| Net Income Continuous | 508,700 | 132,300 | 873,600 | 822,000 | 834,800 |
| Net Income | $508,700 | $132,300 | $873,600 | $822,000 | $834,800 |
| EPS Basic Total Ops | 0.47 | 0.12 | 0.80 | 0.76 | 0.77 |
| EPS Basic Continuous Ops | 0.47 | 0.12 | 0.81 | 0.76 | 0.77 |
| EPS Diluted Total Ops | 0.47 | 0.12 | 0.80 | 0.76 | 0.77 |
| EPS Diluted Continuous Ops | 0.47 | 0.12 | 0.80 | 0.76 | 0.77 |
| EBITDA(a) | $1,049,200 | $1,231,101 | $1,264,000 | $1,202,700 | $1,229,400 |